+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Antiemetics And Antinauseants Global Market Report 2020

  • ID: 4856025
  • Report
  • November 2019
  • Region: Global
  • 200 pages
  • The Business Research Company
1 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Baxter International
  • Daiichi Sankyo Company
  • F. Hoffmann-La Roche
  • IPCA Laboratories
  • Merck
  • MORE
Antiemetics And Antinauseants Market Global Report 2020 from the author provides strategists, marketers and senior management with the critical information they need to assess the global antiemetics and antinauseants market.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Description:
Where is the largest and fastest growing market for the antiemetics and antinauseants? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Antiemetics And Antinauseants Market Global Report from the author answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market
  • The Market Characteristics section of the report defines and explains the market.
  • The Market Size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market Segmentations break down market into sub markets.
  • The Regional and Country section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive Landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The Trends and Strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
Scope
  • Markets Covered: 1) By Drug: Dopamine antagonists, NK1 receptor antagonist, Antihistamines (H1 histamine receptor antagonists), Cannabinoids, Benzodiazepines, Anticholinergics, Steroids, 5-HT3 receptor antagonists, Others 2) By Application: Chemotherapy, Motion sickness, Gastroenteritis, General anaesthetics, Opioid analgesics, Dizziness, Pregnancy, Food poisoning, Emotional stress, Others 3) By End Users: Hospital, Medical Center, Clinic, Research Institutes
  • Companies Mentioned: Johnson & Johnson, Sanofi-Aventis, Pfizer, GlaxoSmithKline, Abbott Laboratories
  • Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA
  • Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
  • Time Series: Five years historic and forecast.
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Baxter International
  • Daiichi Sankyo Company
  • F. Hoffmann-La Roche
  • IPCA Laboratories
  • Merck
  • MORE
1. Executive Summary

2. Antiemetics And Antinauseants Market Characteristics

3. Antiemetics And Antinauseants Market Size And Growth
3.1. Global Antiemetics And Antinauseants Historic Market, 2015 - 2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Antiemetics And Antinauseants Forecast Market, 2019 - 2022F, 2025F, 2030F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market

4. Antiemetics And Antinauseants Market Segmentation
4.1. Global Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Dopamine antagonists NK1 receptor antagonist
  • Antihistamines (H1 histamine receptor antagonists) Cannabinoids
  • Benzodiazepines Anticholinergics
  • Steroids 5-HT3 receptor antagonists
  • Others
4.2. Global Antiemetics And Antinauseants Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Chemotherapy Motion sickness
  • Gastroenteritis General anaesthetics
  • Opioid analgesics Dizziness
  • Pregnancy Food poisoning
  • Emotional stress Others
4.3. Global Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Hospital Medical Center
  • Clinic Research Institutes
5. Antiemetics And Antinauseants Market Regional And Country Analysis
5.1. Global Antiemetics And Antinauseants Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
5.2. Global Antiemetics And Antinauseants Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

6. Asia-Pacific Antiemetics And Antinauseants Market
6.1. Asia-Pacific Antiemetics And Antinauseants Market Overview
6.2. Asia-Pacific Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
6.3. Asia-Pacific Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

7. China Antiemetics And Antinauseants Market
7.1. China Antiemetics And Antinauseants Market Overview
7.2. China Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion
7.3. China Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion

8. India Antiemetics And Antinauseants Market
8.1. India Antiemetics And Antinauseants Market Overview
8.2. India Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
8.3. India Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

9. Japan Antiemetics And Antinauseants Market
9.1. Japan Antiemetics And Antinauseants Market Overview
9.2. Japan Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
9.3. Japan Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

10. Australia Antiemetics And Antinauseants Market
10.1. Australia Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
10.2. Australia Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

11. Indonesia Antiemetics And Antinauseants Market
11.1. Indonesia Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
11.2. Indonesia Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

12. South Korea Antiemetics And Antinauseants Market
12.1. South Korea Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
12.2. South Korea Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

13. Western Europe Antiemetics And Antinauseants Market
13.1. Western Europe Antiemetics And Antinauseants Market Overview
13.2. Western Europe Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
13.3. Western Europe Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

14. UK Antiemetics And Antinauseants Market
14.1. UK Antiemetics And Antinauseants Market Overview
14.2. UK Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
14.3. UK Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

15. Germany Antiemetics And Antinauseants Market
15.1. Germany Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
15.2. Germany Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

16. France Antiemetics And Antinauseants Market
16.4. France Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
16.5. France Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

17. Eastern Europe Antiemetics And Antinauseants Market
17.1. Eastern Europe Antiemetics And Antinauseants Market Overview
17.2. Eastern Europe Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
17.3. Eastern Europe Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

18. Russia Antiemetics And Antinauseants Market
18.1. Russia Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
18.2. Russia Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

19. North America Antiemetics And Antinauseants Market
19.1. North America Antiemetics And Antinauseants Market Overview
19.2. North America Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
19.3. North America Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

20. USA Antiemetics And Antinauseants Market
20.1. USA Antiemetics And Antinauseants Market Overview
20.2. USA Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
20.3. USA Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

21. South America Antiemetics And Antinauseants Market
21.1. South America Antiemetics And Antinauseants Market Overview
21.2. South America Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
21.3. South America Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

22. Brazil Antiemetics And Antinauseants Market
22.1. Brazil Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
22.2. Brazil Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

23. Middle East Antiemetics And Antinauseants Market
23.1. Middle East Antiemetics And Antinauseants Market Overview
23.2. Middle East Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
23.3. Middle East Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

24. Africa Antiemetics And Antinauseants Market
24.1. Africa Antiemetics And Antinauseants Market Overview
24.2. Africa Antiemetics And Antinauseants Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
24.3. Africa Antiemetics And Antinauseants Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

25. Antiemetics And Antinauseants Market Competitive Landscape And Company Profiles
25.1. Antiemetics And Antinauseants Market Competitive Landscape
25.2. Antiemetics And Antinauseants Market Company Profiles
25.2.1. Johnson & Johnson
25.2.1.1. Overview
25.2.1.2. Products and Services
25.2.1.3. Strategy
25.2.1.4. Financial Performance
25.2.2. Sanofi-Aventis
25.2.2.1. Overview
25.2.2.2. Products and Services
25.2.2.3. Strategy
25.2.2.4. Financial Performance
25.2.3. Pfizer
25.2.3.1. Overview
25.2.3.2. Products and Services
25.2.3.3. Strategy
25.2.3.4. Financial Performance
25.2.4. GlaxoSmithKline
25.2.4.1. Overview
25.2.4.2. Products and Services
25.2.4.3. Strategy
25.2.4.4. Financial Performance
25.2.5. Abbott Laboratories
25.2.5.1. Overview
25.2.5.2. Products and Services
25.2.5.3. Strategy
25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Antiemetics And Antinauseants Market

27. Antiemetics And Antinauseants Market Trends And Strategies

28. Product Pipeline Analysis

29. Antiemetics And Antinauseants Market Future Outlook and Potential Analysis

30. Appendix
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Baxter International
  • Daiichi Sankyo Company
  • F. Hoffmann-La Roche
  • IPCA Laboratories
  • Merck
  • MORE
The antiemetics and antinauseants market consists of sale of antiemetic and antinauseant drugs and related services. Antiemetic and antinauseant drugs prevent, control or treat, nausea and vomiting caused in general or by other medications, frequent motion sickness, infections, stomach flu or chemotherapy. These drugs block signal messages to the part of the brain that controls nausea and vomiting thus reducing the symptoms of nausea or vomiting.

The global antiemetics and antinauseants market was valued at about $3.94 billion in 2018 and is expected to grow to $4.57 billion at a CAGR of 3.8% through 2022.

The antiemetics and antinauseants market is driven by the increase in the prevalence rate of cancer. Chemotherapy is one of the most recommended treatment to cure cancer, and chemotherapy-induced nausea and vomiting (CINV) are some of the side effects of the treatment. Antiemetics can help prevent CINV in about 60%-70% of patients. According to the WHO reports in 2018, the incidence of cancer globally has risen to 18.1 million new cases and 9.6 million deaths. According to another report by Centers for Disease Control and Prevention, about 650,000 cancer patients in the USA receive chemotherapy in an outpatient oncology clinic each year. The CINV caused by chemotherapy treatments is cured by using antiemetic and antinauseant drugs like Dolasetron (Anzemet®), Ranitidine (Zantac®) and other serotonin 5-HT3 receptor types of antagonists. Increase in the incidence of cancer will increase demand for antiemetics and antinauseants, thereby driving revenue for market.

Lack of awareness about the variety of antiemetic and antinauseant drugs that are available in the market among the practitioners restrains the market. Despite the presence of a range of drugs, the practitioners prescribe the similar drugs to treat patients with different conditions of nausea. Popularity of only a few drugs leads to lower the demand of other drugs and thus restricts the overall growth of this market. For example, the American Society of Clinical Oncology released its first guideline in the ‘Choosing Wisely’ (CW) 2013 campaign to prevent and discourage the overuse of expensive and similar kind of antiemetic drugs for all ailments.

Manufacturers are exploiting nanotechnology in the antiemetics and antinauseants market to deliver therapeutic agents to specific targeted sites in a controlled manner through Nano medicine and Nano delivery systems. Nano medicine is the medical application of nanotechnology which uses nanoparticles to enhance the action of the drug in treatment and nanotechnology is the design, characterization, production, and application of devices, structures and systems by controlled manipulation of size and shape at the nanometer scale. The antiemetic and antinauseant drugs manufacturers are inclining more towards the use of Nano medicine or Nano drug to make the drug effective and increase their revenues. For instance, Merck & Co., an American multinational pharmaceutical company manufactured Aprepitant under the brand name Emend. It is first FDA-approved drug for the prevention of acute chemotherapy-induced nausea and vomiting (CINV) that uses nanotechnology to increase the absorption of the drug more easily and efficiently.

The antiemetics and antinauseants market is regulated by government agencies such as US Food and Drug Administration. In the USA, title 21 of Food and Drug Administration department of health and human services, U.S., part 336, contains conditions that all the Antiemetic and Antinauseant drugs are required to fulfill in order to remain in the market such as definition, regulations, and regulations related to labeling of the antiemetic drug products.

In 2018, LGM Pharma, a API (active pharmaceutical ingredients) and procurement specialist acquired Zeta for an amount undisclosed. This acquisition will help LGM Pharma to broaden its portfolio of products offering to better serve the pharmaceutical industry with a broad range of drugs and complementary services. ZETA PHARMA® is an Egypt based company was established in 2010 and Zetadidox is one of the antiemetic drugs offered under Zeta's portfolio.

Major players in the market are Johnson & Johnson, Sanofi-Aventis, Pfizer, GlaxoSmithKline and Abbott Laboratories.
Note: Product cover images may vary from those shown
5 of 5
  • Johnson & Johnson
  • Sanofi-Aventis
  • Pfizer
  • GlaxoSmithKline
  • Abbott Laboratories
  • Eli Lilly and Company
  • Merck
  • Eisai
  • Bristol-Myers Squibb
  • SRS Pharmaceuticals
  • Daiichi Sankyo Company
  • Novartis AG
  • Mirabilia Sciences Pvt
  • Baxter International
  • Astellas Pharma
  • Novartis
  • F. Hoffmann-La Roche
  • Braun
  • IPCA Laboratories
  • Kyowa Hakko Kirin Pharma
  • Helsinn Healthcare
  • Tesaro
  • Teva Pharmaceutical Industries Ltd
  • Acacia Pharma
Note: Product cover images may vary from those shown
6 of 5

Loading
LOADING...

Adroll
adroll